Physician profile
Kevin I Perry
NPI 1386872240
$955,180.10
in general payments reported to CMS, 2019-2025
10 companies · $280K in 2025
The $280K reported for 2025 was more than what 98% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,792 · 2020: $13K · 2021: $58K · 2022: $118K · 2023: $309K · 2024: $172K · 2025: $280K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $558K · Royalty Or License: $150K · Travel and Lodging: $43K · Food and Beverage: $6,540 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $4,000.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $557,923.78 |
| Royalty Or License | $150,000.00 |
| Travel and Lodging | $42,789.05 |
| Food and Beverage | $6,539.60 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $4,000.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $591,168.81 | 2019-2025 | Velys, Actis, Attune |
| Depuy Synthes Products, INC. | $342,024.24 | 2020-2025 | Attune, Velys, Reclaim |
| Synthes Gmbh | $12,056.37 | 2022-2025 | |
| Smith+Nephew, INC. | $5,650.75 | 2019-2024 | Journey II, Real Intelligence, Or3o Dual Mobility |
| Stryker Corporation | $2,248.77 | 2019-2022 | |
| Depuy Synthes Sales INC. | $1,412.44 | 2019-2025 | Attune, Actis |
| Zimmer Biomet Holdings, INC. | $467.60 | 2019-2024 | Persona |
| Henry Schein, INC. | $107.10 | 2024 | |
| Medacta USA, INC. | $23.09 | 2019 | |
| Sumitomo Pharma America, INC. | $20.93 | 2025 | Gemtesa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kevin Perry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.